User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Sustained hypoglycemia with therapeutic use of repaglinide.

Primary tabs

download
  • Open access
  • PDF
  • 162.98 K
Hantson, Philippe [UCL] El Balkhi, Souleiman Haufroid, Vincent [UCL] Laterre, Pierre-François [UCL]

Repaglinide is a short-acting insulin secretagogue used for the reduction in postprandial glucose levels in diabetic patients. It has a favorable safety profile with a low risk of hypoglycemia. Prolonged hypoglycemia appears exceptional due to the short serum elimination half-life. [...]

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2020
Language Anglais
Journal information "Acta diabetologica" - Vol. 57, p. 751–753 (2020)
Peer reviewed yes
Publisher Springer Verlag ((Germany) Berlin)
issn 0940-5429
e-issn 1432-5233
Publication status Publié
Affiliations UCL - SSS/IREC/MEDA - Pôle de médecine aiguë
UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology
UCL - (SLuc) Service de biochimie médicale
UCL - (SLuc) Service de soins intensifs
Links
Bibliographic reference Hantson, Philippe ; El Balkhi, Souleiman ; Haufroid, Vincent ; Laterre, Pierre-François. Sustained hypoglycemia with therapeutic use of repaglinide.. In: Acta diabetologica, Vol. 57, p. 751–753 (2020)
Permanent URL http://hdl.handle.net/2078.1/225850